Long-acting injectables (LAIs) Market, By Product Type (Antipsychotics, Hormonal agents, and Anti-infectives), By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4737
|
Published Date
February 2026
|
Pages
365
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Long-acting injectables (LAIs) Market size was valued at USD 16,860.30 Million in 2024, expanding to a CAGR of 13.01% from 2025 to 2032.
Long-acting injectables (LAIs) are advanced parenteral drug delivery systems that maintain therapeutic drug concentration for extended periods through controlled release from biodegradable or depot-based formulations, reducing dosing frequency and improving persistence in chronic therapy. The market is gaining traction as public health systems focus on adherence-driven outcomes in psychiatric, infectious disease, and endocrine care. According to global health agency estimates, poor adherence in long-term therapies ranges between 30–50%, leading to avoidable disease progression and higher institutional treatment costs, which positions LAIs as a cost-optimization tool for government-funded programs. Expansion of community treatment models, inclusion of depot therapies in national formularies, and rising procurement through public healthcare channels are structurally supporting demand for long-duration injectable platforms.
Long-acting injectables (LAIs) Market- Market Dynamics
Rising Chronic Disease Burden and Focus on Medication Adherence to Drive Market Growth
Long-acting injectables (LAIs) are increasingly driving market growth by significantly improving medication adherence compared with daily oral therapies. Chronic conditions, particularly psychiatric disorders such as schizophrenia and bipolar disorder, often face high rates of non-adherence, leading to relapses, frequent hospitalizations, and increased healthcare costs. LAIs provide sustained drug release over several weeks or months, maintaining stable therapeutic levels in the body and eliminating the need for daily dosing. This approach simplifies treatment routines, reduces relapse risk, decreases hospital admissions, and eases the overall burden on healthcare systems. The reduced frequency of administration enhances patient convenience, supports long-term disease management, and positions LAIs as a preferred choice for both patients and healthcare providers.
In addition, the rising prevalence of chronic and long-term health conditions—including psychiatric disorders, HIV/AIDS, diabetes, and hormonal imbalances—is further boosting market demand. Aging populations and the increasing incidence of lifestyle-related illnesses globally are creating a growing need for therapies that ensure continuous and reliable treatment. LAIs are particularly valuable in conditions where maintaining consistent drug levels is critical and daily oral adherence is challenging. By mitigating the risks associated with missed doses, including disease progression and hospitalization, LAIs improve patient outcomes and expand treatment options. The growing number of patients affected by these chronic diseases broadens the potential market across both developed and emerging regions, reinforcing strong demand. Healthcare providers increasingly favor LAIs for their ability to enhance adherence, reduce medical infrastructure strain, and support sustained disease management. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all global deaths annually, with cardiovascular diseases, diabetes, and mental health disorders being major contributors.
Long-acting injectables (LAIs) Market- Segmentation Analysis:
The Global Long-acting injectables (LAIs) Market is segmented on the basis of Product Type, Route of Administration, Application, End User, and Region.
The antipsychotics segment held the largest share of the global long-acting injectables (LAI) market in 2024. These formulations are primarily used to manage chronic psychiatric conditions such as schizophrenia, bipolar disorder, and other severe mental illnesses. Long-acting antipsychotics provide sustained therapeutic drug levels over weeks or months, reducing fluctuations that can lead to relapse and minimizing side effects associated with oral medications. This predictable pharmacokinetic profile enhances treatment adherence and improves overall patient outcomes. Governments are increasingly recognizing the public health importance of mental health management: for example, in 2023, the World Health Organization reported that over 25% of countries had implemented national mental health policies promoting long-acting treatments to improve adherence, reduce hospitalizations, and lower societal healthcare costs.
Based on application, the psychiatric disorders segment leads the LAI market. This dominance is driven by the combination of large patient populations, the chronic nature of psychiatric illnesses, adherence challenges with daily oral medications, and the strong clinical benefits offered by long-acting therapies. LAIs have been shown to reduce relapse rates, hospital admissions, and the overall burden on healthcare systems, providing consistent and reliable treatment for severe psychiatric conditions where missed doses can have serious consequences. Governments are supporting this approach through public health initiatives and funding programs. For instance, the U.S. National Institute of Mental Health (NIMH) allocated over USD 300 million in 2024 for research and implementation programs aimed at improving treatment adherence and outcomes in severe mental disorders, highlighting the growing recognition of long-acting therapies in national mental health strategies.
Long-acting injectables (LAIs) Market- Geographical Insights
North America currently leads the Long-Acting Injectables (LAIs) market, driven by widespread adoption in psychiatric care, a well-established healthcare infrastructure, comprehensive insurance coverage, and early access to innovative therapies. The United States is the primary contributor within the region, supported by growing awareness among healthcare providers and patients regarding the benefits of LAIs in improving medication adherence, reducing relapse rates, and optimizing long-term disease management. According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 4.5% of U.S. adults experienced serious mental illness in 2023, highlighting the large target population for LAI therapies. Ongoing product launches and the availability of newer, more convenient formulations further reinforce market growth in the U.S.
Europe holds the second-largest share of the LAIs market, with countries such as Germany, France, and the United Kingdom leading adoption. The region’s growth is supported by structured mental health programs, rising incidence of chronic psychiatric and endocrine disorders, and increasing demand for long-acting hormonal therapies. According to Eurostat, approximately 83 million Europeans (over 15% of the adult population) were affected by chronic mental health or endocrine disorders in 2023, reflecting the significant potential for LAI-based interventions. These statistics underscore how government-led health initiatives and public awareness campaigns in both North America and Europe are driving adoption of long-acting injectable therapies.
United States- Long-acting injectables (LAIs) Market- Key Insights
The growth of the U.S. market is driven by widespread adoption of long-acting injectables (LAIs) in psychiatric care, supported by a robust healthcare infrastructure and comprehensive insurance coverage. According to the National Institute of Mental Health (NIMH), approximately 7.8 million U.S. adults experienced serious mental illnesses, including schizophrenia and bipolar disorder, in 2022, creating strong demand for treatments that improve medication adherence and reduce relapse risk. LAIs provide sustained medication delivery over weeks or months, maintaining stable therapeutic levels, minimizing hospitalizations, and enabling more effective long-term disease management. Market expansion is further fueled by ongoing product innovation, including newer antipsychotic formulations with extended dosing intervals, enhanced tolerability, and more convenient administration methods. Increased awareness among healthcare providers and patients about the clinical benefits and cost-effectiveness of LAIs continues to accelerate adoption. Additionally, U.S. federal programs, such as the Substance Abuse and Mental Health Services Administration (SAMHSA) grants for community mental health services, promote access to advanced treatment options, further supporting market growth.
Long-acting injectables (LAIs) Market- Competitive Landscape:
The Long Acting Injectables (LAIs) market in 2025 is moderately competitive, driven by leading global pharmaceutical companies that focus on product innovation, therapeutic expansion, and strategic market launches. Johnson & Johnson and Pfizer continue to hold significant revenue shares, offering extensive LAI portfolios across psychiatric and oncology indications. These companies strengthen their market leadership through initiatives that enhance patient adherence, including robust support programs, educational resources, and convenient dosing schedules. Their emphasis on innovation sets industry benchmarks, while ongoing competition accelerates the development of novel delivery technologies and patient-centric solutions, making the LAI sector one of the most dynamic segments in the pharmaceutical industry today.
Recent Developments:
- In 2025, Lupin received U.S. FDA approval for its risperidone longacting injectable, which also obtained 180-day Competitive Generic Therapy (CGT) exclusivity. This formulation represents the first product developed under Lupin’s PrecisionSphere LAI technology platform, highlighting the company’s advances in sustained-release injectable therapies.
- In December 2025, Teva Pharmaceuticals submitted a New Drug Application (NDA) to the U.S. FDA for its olanzapine extended-release injectable suspension (TEV749), designed as a once-monthly treatment for adults with schizophrenia.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET KEY PLAYERS
- Johnson & Johnson
- Pfizer
- Eli Lilly
- ViiV Healthcare
- Teva Pharmaceuticals
- Alkermes
- Lupin Limited
- Amneal Pharmaceuticals
- Sanofi
- Novartis
- Bristol-Myers Squibb
- GlaxoSmithKline (GSK)
- AbbVie
- Roche
- Sun Pharmaceutical Industries
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Antipsychotics
- Hormonal agents
- Anti-infectives
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032
- Intramuscular
- Intravenous (IV)
- Subcutaneous
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Psychiatric disorders
- HIV/AIDS
- Pain & chronic diseases
- Endocrine disorders
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Clinics & Specialty Centers
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Long-acting injectables (LAIs) Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Long-acting injectables (LAIs) Market Snippet by Product Type
2.1.2. Long-acting injectables (LAIs) Market Snippet by Route of Administration
2.1.3. Long-acting injectables (LAIs) Market Snippet by Application
2.1.4. Long-acting injectables (LAIs) Market Snippet by End User
2.1.5. Long-acting injectables (LAIs) Market Snippet by Country
2.1.6. Long-acting injectables (LAIs) Market Snippet by Region
2.2. Competitive Insights
3. Long-acting injectables (LAIs) Key Market Trends
3.1. Long-acting injectables (LAIs) Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Long-acting injectables (LAIs) Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Long-acting injectables (LAIs) Market Opportunities
3.4. Long-acting injectables (LAIs) Market Future Trends
4. Long-acting injectables (LAIs) Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Long-acting injectables (LAIs) Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Long-acting injectables (LAIs) Market Landscape
6.1. Long-acting injectables (LAIs) Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Long-acting injectables (LAIs) Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Antipsychotics
7.1.3. Hormonal agents
7.1.4. Anti-infectives
7.1.5. Others
8. Long-acting injectables (LAIs) Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
8.1.2. Intramuscular
8.1.3. Intravenous (IV)
8.1.4. Subcutaneous
9. Long-acting injectables (LAIs) Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Psychiatric disorders
9.1.3. HIV/AIDS
9.1.4. Pain & chronic diseases
9.1.5. Endocrine disorders
9.1.6. Others
10. Long-acting injectables (LAIs) Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Clinics & Specialty Centers
10.1.4. Others
11. Long-acting injectables (LAIs) Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Long-acting injectables (LAIs) Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Long-acting injectables (LAIs) Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Long-acting injectables (LAIs) Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Long-acting injectables (LAIs) Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Long-acting injectables (LAIs) Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Long-acting injectables (LAIs) Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Johnson & Johnson
12.2.2. Pfizer
12.2.3. Eli Lilly
12.2.4. ViiV Healthcare
12.2.5. Teva Pharmaceuticals
12.2.6. Alkermes
12.2.7. Lupin Limited
12.2.8. Amneal Pharmaceuticals
12.2.9. Sanofi
12.2.10. Novartis
12.2.11. Bristol-Myers Squibb
12.2.12. GlaxoSmithKline (GSK)
12.2.13. AbbVie
12.2.14. Roche
12.2.15. Sun Pharmaceutical Industries
12.2.16. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET KEY PLAYERS
- Johnson & Johnson
- Pfizer
- Eli Lilly
- ViiV Healthcare
- Teva Pharmaceuticals
- Alkermes
- Lupin Limited
- Amneal Pharmaceuticals
- Sanofi
- Novartis
- Bristol-Myers Squibb
- GlaxoSmithKline (GSK)
- AbbVie
- Roche
- Sun Pharmaceutical Industries
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Antipsychotics
- Hormonal agents
- Anti-infectives
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032
- Intramuscular
- Intravenous (IV)
- Subcutaneous
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Psychiatric disorders
- HIV/AIDS
- Pain & chronic diseases
- Endocrine disorders
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Clinics & Specialty Centers
- Others
GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
